Drugs: a new dependent remains from January



[ad_1]



Since 2015, pharmacists have been receiving dispensing fees to compensate for the decline in their margins related to the government-mandated decline in drug prices and their volume. Fees paid by Health Insurance (for 2/3) and complementary health (for the remaining 1/3).

For example, until December 31st, when a pharmacist sells a prescribed medicine box, he receives 1.02 euro fixed.

The entry into force of a conventional agreement pbaded in 2017 between pharmacists and the Health Insurance will lead to the increase of these compensations as from January 2019.

End of systematic repayment

For the moment, the Health Insurance will continue to support 2/3 of the fees. It has also planned a financing plan of 280 million euros over 3 years. However, some complementary health will refuse next year to contribute to the compensations perceived by pharmacists on drugs reimbursed at 15%. It is therefore the patient who will pay the difference.

"The Health Insurance confirmed it to us at a meeting on November 14: if their contracts do not provide for reimbursement of drugs at 15% or 30%, additional health will not participate in the fees of pharmacists", insists Philippe Gaertner, President of the FSPF (Federation of Pharmaceutical Syndicates of France) to our colleagues in Paris. Before continuing, "we will create a new dependent at the moment when we try to remove them".

Specifically, a box of sleeping pills (Stilnox), sold at 3.90 euros in pharmacy but partially reimbursed now costs 2.63 euros to a patient. In 2020, after the last stage of the reform, it will cost him 4.31 euros, or 64% increase.

[ad_2]
Source link